A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment

医学 促红细胞生成素 贫血 内科学 心力衰竭 肾脏疾病 不利影响 临床终点 肾功能 透析 胃肠病学 随机对照试验 内分泌学
作者
Akira Sezai,Masanori Abe,Takashi Maruyama,Makoto Taoka,Hisakuni Sekino,Masashi Tanaka
出处
期刊:Journal of Clinical Medicine [MDPI AG]
卷期号:13 (10): 2764-2764
标识
DOI:10.3390/jcm13102764
摘要

Background/Objectives: Chronic kidney disease (CKD) and anemia are independent prognostic factors for heart failure. In recent years, hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors have become available for the treatment of renal anemia. This prospective randomized controlled study aimed to investigate the effects of switching from a continuous erythropoietin receptor activator (CERA) to one of four HIF-PH inhibitors in patients with chronic heart failure and renal anemia. Methods: Forty patients were randomized by the envelop method to receive treatment with roxadustat, daprodustat, vadadustat, or molidustat. The primary endpoint was the change in the hemoglobin (Hb) level. Secondary endpoints included changes in erythropoietin, changes in free T3, free T4, and thyroid-stimulating hormone (TSH), adverse effects, and drug dose increases and decreases. This study was preregistered in the University Hospital Medical Information Network Clinical Trials Registry (study ID: UMIN000041651). Results: We found no statistically significant difference between Hb levels with HIF-PH inhibitors and CERA, but at month 6, the Hb level was significantly higher with roxadustat than with vadadustat and daprodustat. Erythropoietin decreased significantly after switching to HIF-PH inhibitors. HIF-PH inhibitors had various significant effects on free T3, free T4, and TSH. No adverse events occurred. The doses of some drugs had to be increased or decreased. Conclusions: In patients with heart failure and renal anemia receiving CERA, Hb, NT-ProBNP, and renal function were similar after switching from CERA to HIF-PH inhibitors. The individual HIF-PH inhibitors appear to have different effects on anemia and thyroid function. However, because this was a single-center study with a limited sample size, the efficacy and potential limitations of HIF-PH inhibitors need to be further clarified.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xx完成签到 ,获得积分10
刚刚
1秒前
YH完成签到,获得积分20
1秒前
科研小白完成签到,获得积分10
2秒前
3秒前
3秒前
3秒前
吕培森完成签到 ,获得积分20
4秒前
戈惜发布了新的文献求助10
4秒前
Lucas应助林大壮采纳,获得10
4秒前
一只大肥猫完成签到,获得积分10
4秒前
Orange应助彩色橘子采纳,获得10
5秒前
英俊的雁易完成签到,获得积分10
5秒前
巴啦啦能量完成签到,获得积分10
5秒前
斯文败类应助孤舟采纳,获得10
6秒前
小马甲应助lijiajun采纳,获得10
7秒前
俏皮易绿完成签到 ,获得积分10
7秒前
乐乐应助zz采纳,获得10
7秒前
cloudyick发布了新的文献求助10
7秒前
7秒前
有光光光光光光完成签到,获得积分10
7秒前
B_snow发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
luoyn发布了新的文献求助10
10秒前
认真飞瑶完成签到 ,获得积分10
10秒前
10秒前
烟花应助科研通管家采纳,获得10
10秒前
鲤鱼谷波完成签到,获得积分10
10秒前
李健应助科研通管家采纳,获得10
10秒前
FashionBoy应助科研通管家采纳,获得10
10秒前
Akim应助科研通管家采纳,获得10
10秒前
FashionBoy应助科研通管家采纳,获得30
11秒前
完美世界应助科研通管家采纳,获得10
11秒前
11秒前
科研通AI2S应助科研通管家采纳,获得10
11秒前
11秒前
11秒前
11秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3143314
求助须知:如何正确求助?哪些是违规求助? 2794476
关于积分的说明 7811257
捐赠科研通 2450676
什么是DOI,文献DOI怎么找? 1303944
科研通“疑难数据库(出版商)”最低求助积分说明 627160
版权声明 601386